176905

Anthrax Protective Antigen

from Recombinant, >90% (SDS-PAGE), lyophilized, anthrax protective antigen, Calbiochem^®

• Synonyma: Anthrax PA
• UNSPSC Code: 12352202
• NACRES: NA.77

Vlastnosti

• Název produktu: Anthrax Protective Antigen, Bacillus anthracis, Recombinant, B. anthracis, Anthrax Protective Antigen, Bacillus anthracis, Recombinant, is the protective antigen that mediates the entry of anthrax lethal factor and edema factor into the target cell.
• form: lyophilized
• manufacturer/tradename: Calbiochem^®
• storage condition: OK to freeze
• solubility: soluble (Reconstitute in 100 µl sterile, distilled H2O to yield a final concentration of 1 mg/ml.)
• shipped in: ambient
• storage temp.: 2-8°C
• Quality Level: 100

Popis

Analysis Note

Single major band by SDS-PAGE. Several smaller minor components are apparent that may represent cleavage fragments of the PA.

Biochem/physiol Actions

Cell permeable: no

Primary Target
Type I membrane protein with a von Willebrand factor A domain called anthrax toxin receptor

Product does not compete with ATP.

Reversible: no

Disclaimer

Toxicity: Standard Handling (A)

General description

Recombinant, Bacillus anthracis anthrax protective antigen expressed in a special strain of B. anthracis. One of three protein components of anthrax toxin produced by the pathogenic bacterium, Bacillus anthracis. Central moiety that mediates entry of lethal factor (LF) and edema factor (EF) into the target cell. PA83 binds to the cell surface via a type I membrane receptor with a von Willebrand factor A domain, known as anthrax toxin receptor. PA83 is proteolytically activated in vivo by a furin-like protease to produce a 63 kDa protein (PA63). PA63 self-associates to form a heptameric, cation-selective, voltage-gated, membrane channel that subsequently binds to LF and/or EF. Cleavage of the 20 kDa fragment from PA83 is necessary for binding of protective antigen to LF and EF.

Other Notes

Mogridge, J., et al. 2002. Biochemistry41, 1079.
Nassi, S., et al. 2002. Biochemistry41, 1445.
Ahuja, N., et al. 2001. Biochem. Biophys. Res. Commun.286, 6.
Bradley, K.A., et al. 2001. Nature414, 225.
Brossier, F., and Mock, M. 2001. Toxicon39, 1747.

Packaging

yes

Physical form

Lyophilized from 50 mM NaCl, 5 mM HEPES, pH 7.5.

Preparation Note

Following reconstitution aliquot and freeze (-20°C). Avoid freeze/thaw cycles of solutions. Stock solutions are stable for up to 6 months at -20°C.

Reconstitute in 100 µl sterile, distilled H₂O to yield a final concentration of 1 mg/ml.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Bezpečnostní informace

• Skladovací třída: 11 - Combustible Solids
• wgk: WGK 1
• flash_point_f: Not applicable
• flash_point_c: Not applicable